Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D7ZA
|
||||
| Former ID |
DNC007518
|
||||
| Drug Name |
Ser-Tyr-Ser-Nle-Glu-His-Dphe-Arg
|
||||
| Indication | Discovery agent | Investigative | [528799] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C76H108N20O19
|
||||
| Canonical SMILES |
CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=C<br />C=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C<br />(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)O)NC<br />(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)N
|
||||
| InChI |
1S/C76H108N20O19/c1-4-5-18-51(88-72(111)59(40-98)94-70(109)55(90-64(103)49(78)39-97)33-44-23-25-47(99)26-24-44)66(105)89-53(27-28-62(101)102)68(107)93-58(35-46-37-81-41-85-46)71(110)91-56(32-43-15-7-6-8-16-43)69(108)87-52(21-13-30-82-76(79)80)67(106)92-57(34-45-36-83-50-19-10-9-17-48(45)50)65(104)84-38-61(100)86-54(20-11-12-29-77)74(113)96-31-14-22-60(96)73(112)95-63(42(2)3)75(114)115/h6-10,15-17,19,23-26,36-37,41-42,49,51-60,63,83,97-99H,4-5,11-14,18,20-22,27-35,38-40,77-78H2,1-3H3,(H,81,85)(H,84,104)(H,86,100)(H,87,108)(H,88,111)(H,89,105)(H,90,103)(H,91,110)(H,92,106)(H,93,107)(H,94,109)(H,95,112)(H,101,102)(H,114,115)(H4,79,80,82)/t49-,51-,52-,53-,54-,55-,56+,57-,58-,59-,60-,63-/m0/s1
|
||||
| InChIKey |
RLJQBYDPIVYMOS-PVTUMTKLSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Melanocortin-4 receptor | Target Info | Inhibitor | [528799] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Pathway Interaction Database | Syndecan-3-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.